Invention Grant
- Patent Title: Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
- Patent Title (中): 双胍衍生物,其制备方法以及含有活性成分的药物组合物
-
Application No.: US13520905Application Date: 2011-01-06
-
Publication No.: US09133110B2Publication Date: 2015-09-15
- Inventor: Sung Wuk Kim , Sung Soo Jun , Chang Hee Min , Se Hwan Park , Yong Eun Kim , Duck Kim , Ji Sun Lee , Ju Hoon Oh
- Applicant: Sung Wuk Kim , Sung Soo Jun , Chang Hee Min , Se Hwan Park , Yong Eun Kim , Duck Kim , Ji Sun Lee , Ju Hoon Oh
- Applicant Address: KR
- Assignee: Hanall Biopharma Co., Ltd.
- Current Assignee: Hanall Biopharma Co., Ltd.
- Current Assignee Address: KR
- Agency: Swanson & Bratschun, L.L.C.
- Priority: KR10-2010-0001021 20100106; KR10-2011-0001442 20110106
- International Application: PCT/KR2011/000098 WO 20110106
- International Announcement: WO2011/083999 WO 20110714
- Main IPC: A61K31/38
- IPC: A61K31/38 ; A61K31/36 ; C07D307/02 ; C07C277/00 ; C07C279/26

Abstract:
A biguanide derivative compound with N4-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK and inhibition of cancer cell proliferation in a low dose, compared with conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
Public/Granted literature
Information query